Literature DB >> 6468242

Hyperosmolarity response of ocular standing potential as a clinical test for retinal pigment epithelium activity. Rhegmatogenous retinal detachment.

K Kawasaki, S Madachi-Yamamoto, D Yonemura.   

Abstract

The hyperosmolarity response of the ocular standing potential was recorded in unilateral rhegmatogenous retinal detachment (8 eyes) and in the fellow 'healthy' eye (8 eyes). The hyperosmolarity response was greatly suppressed (M-4 SD: M and SD indicate respectively the mean and the standard deviation in normal subjects) in all affected eyes (p less than 0.005), and slightly abnormal in 2 fellow eyes. The L/D ratio was normal in 2 affected eyes and in all fellow eyes. The hyperosmolarity response in the affected eyes was still greatly suppressed 14 months after successful surgical treatment.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6468242

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  5 in total

Review 1.  Clinical electrophysiology of the retinal pigment epithelium.

Authors:  M F Marmor
Journal:  Doc Ophthalmol       Date:  1991       Impact factor: 2.379

2.  Suppression of the hyperosmolarity response after cataract surgery.

Authors:  K Kawasaki; D Yonemura; T Yanagida; Y Segawa; K Wakabayashi; S Mukoh; H Ishida; S Fujii; Y Takahara
Journal:  Doc Ophthalmol       Date:  1986-11-15       Impact factor: 2.379

3.  Effects of retinal detachment surgery on standing potential.

Authors:  H Iijima; I Watanabe; S Satoh; C Seto
Journal:  Doc Ophthalmol       Date:  1986-07-15       Impact factor: 2.379

4.  Hyperosmolarity-induced hyperpolarization of the membrane potential of the retinal pigment epithelium.

Authors:  S Mukoh; K Kawasaki; D Yonemura; J Tanabe
Journal:  Doc Ophthalmol       Date:  1985-10-15       Impact factor: 2.379

5.  Combined photic and nonphotic electro-oculographic responses in the clinical evaluation of the retinal pigment epithelium.

Authors:  T Mori; M F Marmor; K Miyoshi; Y Tazawa
Journal:  Doc Ophthalmol       Date:  1991       Impact factor: 2.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.